The FDA Strikes Again at Calithera Biosciences
Calithera Biosciences receives a Fast Track designation for its kidney cancer treatment, sending shares higher......»»
Calithera Biosciences and Antengene announce license agreement for CB-708
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mid-Afternoon Market Update: Dow Tumbles Over 500 Points; Calithera Biosciences Shares Slide
Toward the end of trading Monday, the Dow traded down 1.77% to 30,065.47 while the NASDAQ fell 1.83% to 12,652.84. The S&P also fell, dropping 1.83% to 3,687.43. read more.....»»
Calithera Biosciences expects cash to be sufficient through 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Is It Moving? Analyzing The Downward Movement in Calithera Biosciences"s Stock Today
Calithera Biosciences’s Stock Price An.....»»
Calithera Biosciences to host business news update conference call
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences price target raised to $10 from $7 at Citi
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences reports Q1 EPS (38c), consensus (36c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
First Week of December 18th Options Trading For Calithera Biosciences (CALA)
Stock Options Channel.....»»
Calithera Biosciences 5M share Spot Secondary priced at $6.25
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences announces common stock offering, no amount given
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences expects to delay enrollment in CB-280 trial until Q3
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences says INCB001158 trials are "ongoing as planned"
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences expects to delay enrollment in KEAPSAKE trial until Q3
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences expects top-line data from CANTATA trial in Q4
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences delaying start of enrollment in two clinical trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences initiated with a Buy at Jefferies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences Reports Fourth Quarter 2019 Financial Results and Recent Highlights
SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of c.....»»
Calithera Biosciences announces 2020 milestones
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Calithera Biosciences announces new employment inducement grants
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»